Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Benitec Biopharma (BNTC) Prepaid Assets (2019 - 2025)

Benitec Biopharma has reported Prepaid Assets over the past 7 years, most recently at $562000.0 for Q4 2025.

  • Quarterly results put Prepaid Assets at $562000.0 for Q4 2025, up 53.55% from a year ago — trailing twelve months through Dec 2025 was $562000.0 (up 53.55% YoY), and the annual figure for FY2025 was $628000.0, up 21.71%.
  • Prepaid Assets reached $562000.0 in Q4 2025 per BNTC's latest filing, up from $480000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $1.2 million in Q2 2023 and bottomed at $157000.0 in Q1 2024.
  • Median Prepaid Assets over the past 5 years was $481000.0 (2023), compared with a mean of $515650.0.
  • The largest annual shift saw Prepaid Assets skyrocketed 275.73% in 2023 before it crashed 79.72% in 2024.
  • Over 5 years, Prepaid Assets stood at $338000.0 in 2021, then grew by 5.33% to $356000.0 in 2022, then fell by 0.28% to $355000.0 in 2023, then grew by 3.1% to $366000.0 in 2024, then surged by 53.55% to $562000.0 in 2025.
  • Business Quant data shows Prepaid Assets for BNTC at $562000.0 in Q4 2025, $480000.0 in Q3 2025, and $628000.0 in Q2 2025.